Marino Brunori

1.0k total citations
30 papers, 649 citations indexed

About

Marino Brunori is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Marino Brunori has authored 30 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 20 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Marino Brunori's work include Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (12 papers) and Cancer Treatment and Pharmacology (8 papers). Marino Brunori is often cited by papers focused on Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (12 papers) and Cancer Treatment and Pharmacology (8 papers). Marino Brunori collaborates with scholars based in Italy, Germany and Brazil. Marino Brunori's co-authors include Massimo Offidani, Attilio Olivieri, Pietro Leoni, Mauro Montanari, Laura Corvatta, Debora Capelli, Massimo Catarini, Riccardo Centurioni, Marco Candela and Antonella Poloni and has published in prestigious journals such as Blood, Clinical Infectious Diseases and British Journal of Haematology.

In The Last Decade

Marino Brunori

29 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marino Brunori Italy	16	416	334	205	90	77	30	649
Taru Kuittinen Finland	18	468 1.1×	390 1.2×	82 0.4×	157 1.7×	73 0.9×	44	817
Ignacio Lorenzo Spain	17	685 1.6×	239 0.7×	183 0.9×	99 1.1×	226 2.9×	34	946
Patrizia Zappasodi Italy	15	446 1.1×	368 1.1×	224 1.1×	27 0.3×	96 1.2×	48	693
Sam Penza United States	17	467 1.1×	321 1.0×	103 0.5×	118 1.3×	88 1.1×	63	806
J.P. Laporte France	12	272 0.7×	207 0.6×	60 0.3×	171 1.9×	94 1.2×	32	574
Luciano Masini Italy	10	428 1.0×	266 0.8×	303 1.5×	35 0.4×	64 0.8×	21	575
Riccardo Centurioni Italy	15	457 1.1×	236 0.7×	156 0.8×	67 0.7×	93 1.2×	40	685
Giuseppe Irrera Italy	18	572 1.4×	337 1.0×	128 0.6×	34 0.4×	94 1.2×	51	828
Oren Pasvolsky Israel	14	337 0.8×	137 0.4×	111 0.5×	84 0.9×	143 1.9×	64	609
Kyu Bo Lee South Korea	15	348 0.8×	229 0.7×	111 0.5×	121 1.3×	105 1.4×	38	681

Countries citing papers authored by Marino Brunori

Since Specialization

Citations

This map shows the geographic impact of Marino Brunori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marino Brunori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marino Brunori more than expected).

Fields of papers citing papers by Marino Brunori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marino Brunori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marino Brunori. The network helps show where Marino Brunori may publish in the future.

Co-authorship network of co-authors of Marino Brunori

This figure shows the co-authorship network connecting the top 25 collaborators of Marino Brunori. A scholar is included among the top collaborators of Marino Brunori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marino Brunori. Marino Brunori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sodani, Pietro, Rita Girolimetti, Silvia Tedesco, et al.. (2020). Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis. Respiratory Medicine Case Reports. 31. 101115–101115. 13 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2011). Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed–refractory multiple myeloma. Annals of Hematology. 90(12). 1449–1456. 14 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2011). Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide. Leukemia & lymphoma. 52(5). 776–785. 17 indexed citations

Offidani, Massimo, Claudia Polloni, Laura Corvatta, et al.. (2011). Assessment of Frailty Measures and Their Effect on Survival in a Population of Patients Registered At Marche Region Multiple Myeloma (MM) Registry. Blood. 118(21). 2873–2873. 1 indexed citations

Offidani, Massimo, Pietro Leoni, Laura Corvatta, et al.. (2010). ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma. European Journal Of Haematology. 84(6). 474–483. 12 indexed citations

Buda, Gabriele, Alessandro Di Martino, Valentina Maggini, et al.. (2009). MDR1 C3435T Polymorphism Indicates a Different Outcome in Advanced Multiple Myeloma. Acta Haematologica. 122(1). 42–45. 9 indexed citations

Offidani, Massimo, Laura Corvatta, Claudia Polloni, et al.. (2008). Thalidomide‐dexamethasone versus Interferon‐alpha‐dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study. British Journal of Haematology. 144(5). 653–659. 23 indexed citations

Offidani, Massimo, Claudia Polloni, Laura Corvatta, et al.. (2007). ThaDD-V Treatment for Patients with Relapsed/Refractory Multiple Myeloma: A Feasibility/Activity Study.. Blood. 110(11). 2729–2729. 1 indexed citations

Mele, Anna, Massimo Offidani, Giuseppe Visani, et al.. (2007). Technetium‐99m sestamibi scintigraphy is sensitive and specific for the staging and the follow‐up of patients with multiple myeloma: a multicentre study on 397 scans. British Journal of Haematology. 136(5). 729–735. 25 indexed citations

10.

Visani, Giuseppe, Attilio Olivieri, Michele Malagola, et al.. (2006). Consolidation therapy for adult acute myeloid leukemia: A systematic analysis according to evidence based medicine. Leukemia & lymphoma. 47(6). 1091–1102. 8 indexed citations

11.

Offidani, Massimo, Laura Corvatta, Giuseppe Visani, et al.. (2006). Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.. PubMed. 91(1). 133–6. 62 indexed citations

12.

Offidani, Massimo, Laura Corvatta, Giuseppe Visani, et al.. (2005). Thalidomide, Dexamethasone and Pegylated-Liposomal Doxorubicin (ThaDD) for Untreated Multiple Myeloma Patients Aged over 65 Years.. Blood. 106(11). 2558–2558. 1 indexed citations

13.

Offidani, Massimo, Laura Corvatta, Attilio Olivieri, et al.. (2004). Thalidomide plus oral melphalan compared with thalidomide alone for advanced multiple myeloma. The Hematology Journal. 5(4). 312–317. 21 indexed citations

14.

Offidani, Massimo, Laura Corvatta, Lara Malerba, et al.. (2004). Common and rare side‐effects of low‐dose thalidomide in multiple myeloma: focus on the dose‐minimizing peripheral neuropathy. European Journal Of Haematology. 72(6). 403–409. 34 indexed citations

15.

Olivieri, Attilio, Debora Capelli, Mauro Montanari, et al.. (2001). Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience. Bone Marrow Transplantation. 27(11). 1189–1195. 32 indexed citations

16.

Offidani, Massimo, Laura Corvatta, Attilio Olivieri, et al.. (2001). A Predictive Model of Varicella-Zoster Virus Infection after Autologous Peripheral Blood Progenitor Cell Transplantation. Clinical Infectious Diseases. 32(10). 1414–1422. 32 indexed citations

17.

Capelli, Debora, Gino Santini, Cármino Antônio De Souza, et al.. (2000). Amifostine can reduce mucosal damage after high‐dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study. British Journal of Haematology. 110(2). 300–307. 45 indexed citations

18.

Olivieri, Attilio, Laura Corvatta, Mauro Montanari, et al.. (1998). Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. Bone Marrow Transplantation. 21(10). 1049–1053. 54 indexed citations

19.

Olivieri, Attilio, Massimo Offidani, Mauro Montanari, et al.. (1998). Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.. PubMed. 83(4). 329–37. 45 indexed citations

20.

Olivieri, Attilio, et al.. (1995). Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization.. PubMed. 16(6). 765–70. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact